Literature DB >> 27237592

Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer.

Felipe Villar Álvarez1, Ignacio Muguruza Trueba2, José Belda Sanchis3, Laureano Molins López-Rodó4, Pedro Miguel Rodríguez Suárez5, Julio Sánchez de Cos Escuín6, Esther Barreiro7, M Henar Borrego Pintado8, Carlos Disdier Vicente9, Javier Flandes Aldeyturriaga10, Pablo Gámez García11, Pilar Garrido López12, Pablo León Atance13, José Miguel Izquierdo Elena14, Nuria M Novoa Valentín15, Juan José Rivas de Andrés16, Íñigo Royo Crespo16, Ángel Salvatierra Velázquez17, Luís M Seijo Maceiras18, Segismundo Solano Reina19, David Aguiar Bujanda20, Régulo J Avila Martínez11, Jose Ignacio de Granda Orive21, Eva de Higes Martinez22, Vicente Diaz-Hellín Gude11, Raúl Embún Flor16, Jorge L Freixinet Gilart5, María Dolores García Jiménez13, Fátima Hermoso Alarza11, Samuel Hernández Sarmiento20, Antonio Francisco Honguero Martínez13, Carlos A Jimenez Ruiz23, Iker López Sanz14, Andrea Mariscal de Alba11, Primitivo Martínez Vallina16, Patricia Menal Muñoz24, Laura Mezquita Pérez12, María Eugenia Olmedo García12, Carlos A Rombolá13, Iñigo San Miguel Arregui25, María de Valle Somiedo Gutiérrez10, Ana Isabel Triviño Ramírez13, Joan Carles Trujillo Reyes3, Carmen Vallejo26, Paz Vaquero Lozano19, Gonzalo Varela Simó15, Javier J Zulueta27.   

Abstract

The Thoracic Surgery and Thoracic Oncology groups of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) have backed the publication of a handbook on recommendations for the diagnosis and treatment of non-small cell lung cancer. Due to the high incidence and mortality of this disease, the best scientific evidence must be constantly updated and made available for consultation by healthcare professionals. To draw up these recommendations, we called on a wide-ranging group of experts from the different specialties, who have prepared a comprehensive review, divided into 4 main sections. The first addresses disease prevention and screening, including risk factors, the role of smoking cessation, and screening programs for early diagnosis. The second section analyzes clinical presentation, imaging studies, and surgical risk, including cardiological risk and the evaluation of respiratory function. The third section addresses cytohistological confirmation and staging studies, and scrutinizes the TNM and histological classifications, non-invasive and minimally invasive sampling methods, and surgical techniques for diagnosis and staging. The fourth and final section looks at different therapeutic aspects, such as the role of surgery, chemotherapy, radiation therapy, a multidisciplinary approach according to disease stage, and other specifically targeted treatments, concluding with recommendations on the follow-up of lung cancer patients and surgical and endoscopic palliative interventions in advanced stages.
Copyright © 2016 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Cáncer de pulmón; Diagnosis; Diagnóstico; Lung cancer; Recomendaciones; Recommendations; Tratamiento; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27237592     DOI: 10.1016/j.arbres.2016.02.016

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.

Authors:  M Majem; J Hernández-Hernández; F Hernando-Trancho; N Rodríguez de Dios; A Sotoca; J C Trujillo-Reyes; I Vollmer; R Delgado-Bolton; M Provencio
Journal:  Clin Transl Oncol       Date:  2019-06-06       Impact factor: 3.405

Review 2.  Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Authors:  Roberto Chalela; Víctor Curull; César Enríquez; Lara Pijuan; Beatriz Bellosillo; Joaquim Gea
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 3.  Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Authors:  Esther Barreiro; Víctor Bustamante; Víctor Curull; Joaquim Gea; José Luis López-Campos; Xavier Muñoz
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 4.  Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer.

Authors:  Sara Montemuiño Muñiz; Soraya Marcos Sánchez; Julia Calzas Rodríguez; Beatriz Losada Vila; Esther Llorente Herrero; María Dolores Hisado Díaz; Victoria Valeri-Busto González; Begoña Taboada Valladares; Blanca Vaquero Barrón; Francisco José Marcos Jimenez; Sergio Amor Alonso; Javier Moradiellos; Núria Rodríguez de Dios; Felipe Couñago
Journal:  J Clin Transl Res       Date:  2021-04-16

5.  Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.

Authors:  Anna Salazar-Degracia; Sílvia Busquets; Josep M Argilés; Francisco J López-Soriano; Esther Barreiro
Journal:  PeerJ       Date:  2017-12-13       Impact factor: 2.984

6.  Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events.

Authors:  Jun Tang; Daniel Ramis-Cabrer; Xuejie Wang; Esther Barreiro
Journal:  Cancers (Basel)       Date:  2019-09-04       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.